Hepatology 12 , 688694 (1990)
Over time, this can help with OSA symptoms, like fewer breathing interruptions during sleep
A direct head-to-head trial (NCT06662383, 800 patients) is underway with results in December 2026
Retatrutide should not be marketed, administered, or used as a personal treatment based on online claims about Retatrutide benefits, weight loss outcomes, or future availability
Patients should discuss with their physicians regarding expected outcomes and timing
And the challenge is that in clinical trials, the randomized controlled trials that study these medications, they typically enroll up to several thousand patients